DistantNews
Support us
Actress Temitope Osoba dies at 40 after cancer battle
๐Ÿ‡ณ๐Ÿ‡ฌ Nigeria /Health & Science

Actress Temitope Osoba dies at 40 after cancer battle

From Premium Times · () English

Translated from English, summarized and contextualized by DistantNews.

At a glance

News Named sources Outcome reported
  • Popular Yoruba actress Temitope Osoba has died at the age of 40 after a battle with breast cancer.
  • Colleagues announced her death on Wednesday, revealing she passed away Tuesday, following several surgeries and a prolonged fight with the illness.
  • Osoba had recently appealed for financial assistance for her treatment and later announced she had beaten the disease, expressing a desire to inspire others and rebrand her career.

Yoruba actress Temitope Osoba has died at 40 after a protracted battle with breast cancer. Her passing was confirmed on Wednesday by industry colleagues, who noted she died the previous day. While the specific cause of death was not disclosed, Osoba had been undergoing treatment for breast cancer, which included multiple surgeries.

Tope is gone, my baby is gone. Ha, iku doro.

โ€” Foluke Daramola-SalakoA colleague's emotional reaction to Temitope Osoba's death.

Her colleagues remembered her as a kind, humble, and caring individual. One colleague, Oladipupo Okanlawon, described her as a friend whose presence brightened every room. He expressed shock at her death, stating that her dedication, warmth, and genuine heart touched many lives. He added that her memory would live on, and he prayed for her eternal rest and comfort for her grieving family and friends.

In loving memory of my dear colleague, Temitope Osoba. It is with a heavy heart that I say goodbye to a wonderful colleague and friend, Temitope Osoba. The news of your passing yesterday came as a great shock, and itโ€™s still hard to believe youโ€™re no longer with us. Your dedication, warmth, and genuine heart touched the lives of so many people. Though your time with us was cut short, the memories you left behind will remain in our hearts forever. Your kindness, laughter, and the impact you made will never be forgotten. I pray that God grants you eternal rest and comforts your family, friends, and everyone grieving this painful loss. May He give us the strength to accept what we cannot understand and the grace to hold on to the beautiful memories we shared.

โ€” Oladipupo OkanlawonA colleague's tribute to Temitope Osoba, remembering her positive impact.

PREMIUM TIMES reported in November 2024 that Osoba had sought financial aid after her first breast cancer surgery. In her last Instagram post on August 4, 2025, she announced she had overcome the disease and was recovering. She stated she had emerged stronger and more resilient, intending to share her story to inspire others. Osoba also thanked her management team for their support and expressed excitement about taking her acting career to the next level, signaling a rebranding and rebuilding phase focused on healing, growth, and empowerment. She also expressed openness to endorsements, roles, and collaborations, aiming to use her platform to support cancer awareness.

Iโ€™m excited to announce my reintroduction. This journey has been a turning point, leading to my rebranding, reshaping, and rebuilding. This new chapter is about healing, growth, and empowerment. Iโ€™m committed to using my platform to support cancer awareness and help others who may be walking a similar path. Iโ€™m also open to exciting opportunities, including endorsements, roles, and event-related collaborations. If youโ€™d like to discuss potential partnerships or opportunities, please feel free to reach out to my management team. Thank you for your unwavering support. Iโ€™m looking forward to this new journey with all of you!

โ€” Temitope OsobaTemitope Osoba's statement about her recovery and future career plans in her last Instagram post.
DistantNews Editorial

Originally published by Premium Times in English. Translated, summarized, and contextualized by our editorial team with added local perspective. Read our editorial standards.